Efficacy and Safety of Camrelizumab Combination Therapy in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis [0.03%]
卡瑞利珠单抗联合治疗三阴性乳腺癌疗效和安全性的系统评价和 meta 分析
Umar Akram,Zain A Nadeem,Obaid Ur Rehman et al.
Umar Akram et al.
Objectives: The role of camrelizumab in combination therapy for triple-negative breast cancer (TNBC) is unclear. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of camrelizumab combinati...
Comparative Efficacy and Safety of Bispecific T-Cell Engagers (BiTEs) Versus Immune Checkpoint Inhibitors (ICIs) in Hematologic Malignancies: A Systematic Review and Meta-Analysis [0.03%]
双特异性T细胞衔接器(BiTEs)与免疫检查点抑制剂(ICIs)在血液系统恶性肿瘤中的有效性和安全性比较：系统评价和Meta分析
Zaheer Qureshi,Abdur Jamil,Kazi Samsuddoha et al.
Zaheer Qureshi et al.
Objectives: Targeted immunotherapies have significantly revolutionized the treatment of hematologic malignancies. Among the most promising immunotherapies are bispecific T-cell engagers (BiTEs) and immune checkpoint inhib...
Predictive Value of PIK3CA Mutations for Response to CDK4/6 Inhibitors in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis [0.03%]
PIK3CA突变对激素受体阳性、HER2阴性转移性乳腺癌CDK4/6抑制剂疗效预测价值的系统评价和meta分析
Zaheer Qureshi,Abdur Jamil,Neehal Wali et al.
Zaheer Qureshi et al.
Background: Currently, cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors combined with hormone therapy are the standard treatment for patients with hormone receptor-positive/human epidermal growth factor receptor 2-neg...
Dual Inhibition of HER2 and VEGF Pathways in Breast Cancer: A Meta-analysis of Outcomes [0.03%]
乳腺癌HER2和VEGF通路双重抑制的结局的 meta 分析
Zaheer Qureshi,Abdur Jamil,Kazi Samsuddoha et al.
Zaheer Qureshi et al.
Objectives: The vascular endothelial growth factor (VEGF) pathway plays a crucial part in tumor angiogenesis by enhancing the creation of new blood vessels that supply oxygen. Breast cancer cells with overexpressed human ...
Transcranial Magnetic Stimulation (TMS) in Cancer Care: A Scoping Review of Safety and Efficacy [0.03%]
经颅磁刺激(TMS)在癌症治疗中的应用：安全性和有效性的系统综述研究
Marie McLaughlin,Ethan Berry,Nilihan N E M Sanal-Hayes
Marie McLaughlin
Cancer remains a growing global health burden, with many survivors experiencing significant psychological symptoms such as fatigue, pain, anxiety, and depression. Noninvasive brain stimulation techniques such as rTMS have gained attention f...
Integrating Genomic Data and Imaging in Lung Cancer Prediction Using a Hybrid Deep Learning Approach [0.03%]
基于混合深度学习方法的肺癌预测中的基因组数据及影像整合研究
Anand Sharma,Narendra M Kandoi
Anand Sharma
Objectives: Lung cancer remains one of the leading causes of cancer-related mortality worldwide, underscoring the urgent need for improved diagnostic and predictive methodologies. The several challenges in the complexity ...
AI-Enabled Early Detection of Chemo-Induced Cardiotoxicity Patterns Using ECG Time Series Data: A Simulated Oncology Framework [0.03%]
基于ECG时间序列数据的AI辅助化疗诱导的心脏毒性的早期检测：模拟肿瘤学框架
Kamal Upreti,Jossy P George,Khushboo Malik et al.
Kamal Upreti et al.
Objectives: Chemotherapy-induced cardiotoxicity is still a major clinical problem, usually appearing subclinically before structural or symptomatic cardiac dysfunction appears. Standard surveillance methods use imaging an...
Accurate Lung Cancer Prediction From CT Scans Using Advanced Deep Learning Methods [0.03%]
基于先进深度学习方法的CT肺癌预后诊断
Anand Sharma,Narendra M Kandoi
Anand Sharma
Objectives: Accurate lung cancer prediction from CT scans using advanced deep learning methods is crucial for improving early diagnosis and treatment outcomes, as it harnesses innovative algorithms to enhance the detectio...
Deep Learning-Based Risk Factor Analysis for Accurate Prediction of Lung Cancer in High-Risk Populations [0.03%]
基于深度学习的肺癌高危人群风险因素分析及准确预测模型研究
Anand Sharma,N M Kandoi
Anand Sharma
Objectives: Lung cancer remains a leading cause of cancer-related deaths worldwide, largely due to late diagnosis and the complexity of its risk factors. Early detection and accurate risk prediction are critical to improv...
Genetic Alterations in NSCLC: Prognostic Implications and Impact on Therapeutic Resistance [0.03%]
非小细胞肺癌的遗传改变：预后价值和对治疗抵抗性的影响
Bhardwaj Tina Neelesh,Kanchan Bhardwaj,Phani Mn et al.
Bhardwaj Tina Neelesh et al.
Worldwide, the incidence of lung cancer is projected to continue its upward trend, with an estimated 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer, accounting for ~85% of all ca...